Thursday, 25 April 2024
  
Login

Australia's most trusted
source of pharma news

Thursday, 25 April 2024
Listen to this story 
News

New name for GSK spin-off

Posted 23 February 2022 PM

GSK has revealed that its consumer healthcare business will be called Haleon following its planned spin-off mid-2022, with Aussie staff set to move into brand new headquarters. 

Anish Patel, ANZ General Manager designate of Haleon said, "the creation of Haleon is an exciting milestone as we move towards our future as a new, standalone consumer healthcare company".

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (5)

Sales & Customer Relations (25)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (7)

Devices (1)

Other (24)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.